|
Following growing concerns that research based in pathology or reliant on pathology was under such pressure in the UK that the development of new and more personalised treatments for patients would be badly affected, the National Cancer Research Institute (NCRI) established the NCRI Pathology & Research Task Force to examine the issues behind this problem.
The Task Force, which comprised a number of pathologists as well as representatives from Cancer Research UK, Medical Research Council, Department of Health and onCore UK, proposed a series of actions to encourage and enable pathologists to engage with research.
Their report, launched in October 2009, identified three key areas where action is needed to:
- Rejuvenate and enable pathology research in medical schools, universities and the NHS
- Create a clear and practical pathway through the regulatory and governance framework to make pathology research more accessible
- Promote and create enhanced recognition of the patient benefit arising from pathology research.
For further information on these action areas click here to view the executive summary and full report.
onCore UK is leading on some of these actions including
- Supporting the further development of the Medical Research Council’s Data and Tissues Took kit (to be relaunched in 2011)
- Hosting workshops in collaboration with NRES to clarify the ethical principles relating to when consent is or is not required for use of anonymised samples in research
|